Series C funding round for Promentis Pharmaceuticals raising $26M in March 2017
Series C funding round for Promentis Pharmaceuticals raising $26M in March 2017
| Investor | Firm Type | Partner |
|---|
OrbiMedLEAD | Venture Capital | — |
| Private | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$29M
Top Valuation
-
Promentis Pharmaceuticals raised $26M in a Series C round.
The round was announced on 03/01/17.
The round was led by OrbiMed, Stacey Seltzer, Thomas Beck.